Resources
Related Tags:
Phase Forward Inc. (9 results)
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Phase Forward: Boooooring
- Phase Forward monitors clinical trials around the world and spurred the move to web-based trials ten years ago. But their boring technology helps us all not die from the latest meds. Which is sort of exciting.
- Videos 2008-04-02
Additional Resources
- Speak with other shareholders about: (NASDAQ: PCCC), (NASDAQ: PFWD), (NASDAQ: ZIGO), (NASDAQ: TTEC).
- M2 PRESSWIRE-26 October 2006-Stockwire.com: Speak with other shareholders about: (NASDAQ: PCCC), (NASDAQ: PFWD), (NASDAQ: ZIGO), (NASDAQ: TTEC)C1994-2006 M2 COMMUNICATIONS LTD RDATE:26102006 AUSTIN - A very interesting indicator to look for is where the money is flowing into. We have a filter...
- Research articles 2006-10-26
- Speak with other shareholders about: (OTCBB:VOII), (NASDAQ:PFWD), (OTC:ACMG) and (OTC:NWACQ).
- M2 PRESSWIRE-14 February 2007-Stockwire.com: Speak with other shareholders about: (OTCBB:VOII), (NASDAQ:PFWD), (OTC:ACMG) and (OTC:NWACQ).C1994-2007 M2 COMMUNICATIONS LTD RDATE:14022007 AUSTIN - A very interesting indicator to look for is where the money is flowing into. We have a filter that we watch...
- Research articles 2007-02-14
- Phase Forward Incorporated Announces Pricing of Initial Public Offering
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD) announced today the initial public offering of 5,250,000 shares of its common stock at $7.50 per share, for aggregate net proceeds of approximately $34,600,000. All of the shares are being offered by Phase Forward. The shares are quoted on the Nasdaq National...
- Research articles 2004-07-15
- Phase Forward Hosts Third Annual International Users Conference
- Phase Forward (NASDAQ: PFWD)--Who: Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety What: Third Annual Phase Forward International Users Conference When: Tuesday, October 26...
- Research articles 2004-10-12
- Phase Forward to Present at the Piper Jaffray 7th Annual Technology Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will participate in the Piper Jaffray 7th Annual Technology Conference to be held in New York, May 11 to 13, 2005. Phase Forward President and...
- Research articles 2005-05-03
- Phase Forward's Safety Data Mining Solution in Production At FDA; Tool Co-Developed with Lincoln Technologies and FDA Helps Agency to Assess the Safety of Drugs
- WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the successful completion of recently acquired Lincoln Technologies' Cooperative Research and Development Agreement CRADA with the FDA to develop advanced analytical tools for drug safety risk assessment. The...
- Research articles 2005-09-08
- Phase Forward to Present at the Piper Jaffray 19th Annual Health Care Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will present at the Piper Jaffray 19th Annual Health Care Conference at the...
- Research articles 2007-11-19
- Phase Forward Names Steve Powell Vice President of Worldwide Sales; Company's VP and GM of International Operations Takes on Worldwide Sales Responsibilities
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Steve Powell, vice president and general manager, international, will now assume responsibility for the company's worldwide sales function in addition to his current role running international...
- Research articles 2005-03-07
- Phase Forward to Present at UBS Global Life Sciences Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and its chief financial officer, Rodger Weismann, will present at the UBS Global Life Sciences Conference at the Grand...
- Research articles 2006-09-11
- Eyetech Pharmaceuticals Utilizes Phase Forward's Inform EDC Solution in Macugen Clinical Trials; Macugen Approved by FDA; Launched in January 2005
- WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Eyetech Pharmaceuticals Inc. (NASDAQ: EYET) utilized the InFormTM electronic data capture EDC solution in clinical trials for its age-related macular degeneration drug MacugenR pegaptanib sodium injection, which...
- Research articles 2005-02-23
- Phase Forward to Present at the UBS Global Healthcare Services Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will present at the UBS Global Healthcare Services Conference at the Grand Hyatt...
- Research articles 2008-02-06
- Phase Forward Continues to Put Safety First; Company's Electronic Case Submissions Module 2.0, Available Immediately, Offers Streamlined Safety Reporting and Enhanced Security; Complies with FDA's Gateway Submission Standards
- WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the immediate availability of a new version (2.0) of the Electronic Case Submissions Module ECSM. The ECSM, together with the ClintraceTM adverse event tracking and reporting system, provides...
- Research articles 2006-08-10
- Phase Forward to Present at the UBS 2007 Global Life Sciences Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and chief financial officer, Rodger Weismann, will present at the UBS 2007 Global Life Sciences Conference at the Grand...
- Research articles 2007-09-19
- Phase Forward to Present at UBS Global Healthcare Services Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will participate in the UBS Global Healthcare Services Conference to be held at the Grand Hyatt New York on February 13-15, 2006. Phase Forward President...
- Research articles 2006-02-01
- Phase Forward to Present at the Friedman, Billings, Ramsey Growth Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its chief executive officer and president, Bob Weiler, and its chief financial officer, Rodger Weismann, will present at the Friedman, Billings, Ramsey and Company Growth Conference at...
- Research articles 2007-05-24
- Phase Forward to Present at the Friedman, Billings, Ramsey Growth Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced its management team will present at the Friedman, Billings, Ramsey Group, Inc. 2006 Growth Conference at the Grand Hyatt New York in New York City on May...
- Research articles 2006-05-18
- Phase Forward to Present at Citigroup Small & Mid-Cap Conference
- WALTHAM, Mass. -- Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will participate in the Citigroup Small & Mid-Cap Conference to be held in the Four Seasons Hotel in Las Vegas on March 14-16, 2006. Phase...
- Research articles 2006-03-01
- Phase Forward Enhances Clinical Adverse Event Reporting and Regulatory Compliance; Clintrace 4.1 Features Reporting Capabilities Achieved Through Integration with Cognos ReportNet, Compliance with FDA MedWatch 3500A Guidelines
- WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced the immediate availability of a new version (4.1) of the ClintraceTM adverse event tracking and reporting system. A comprehensive solution for safety data collection, management and submission, Clintrace...
- Research articles 2006-09-05
- Phase Forward Named to Deloitte's New England Technology Fast 50
- WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has been named to Deloitte's prestigious Technology Fast 50 program. A ranking of the 50 fastest growing technology companies in the New England region area based...
- Research articles 2005-09-26
- << Previous
- page 1 of 1
- Next >>
